Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00622102 · ClinicalTrials.gov registry record · NA
Testing Strategies to Improving Warfarin Adherence
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
NCT00622102: Completed NA study, sponsored by University of Pennsylvania.
NCT00622102 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 101 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00622102, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
Study Summary
We are performing a research study to learn more about the control of an individual's blood thinning (anticoagulation) on warfarin. Individuals from an anticoagulation clinic are being asked to participate in order to see if a lottery which provides the opportunity to win money in combination with the use of the Med-eMonitor might be useful in helping patients to achieve better control of their anticoagulation therapy. Half of the participants will be enrolled in the lottery arm and the other half will be a control group who will receive the Med-eMonitor only.
Interventions
- BEHAVIORAL Lottery arm (Lottery and Med-eMonitor)
- BEHAVIORAL Non-Lottery (Med-eMonitor only)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2007-12 |
| Est. Completion | 2009-04 |
| Phase | NA |
What the finished NCT00622102 record still lists
NCT00622102 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Lottery arm (Lottery and Med-eMonitor) is the first listed.
NCT00622102 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00622102 about?
NCT00622102 is a clinical study titled "Testing Strategies to Improving Warfarin Adherence". We are performing a research study to learn more about the control of an individual's blood thinning (anticoagulation) on warfarin. Individuals from an anticoagulation clinic are being asked to participate in order to see if a lottery which provides the opportunity to win money in combination with t...
What is the current status of trial NCT00622102?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2007-12. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00622102?
The interventions under investigation include: Lottery arm (Lottery and Med-eMonitor) (BEHAVIORAL), Non-Lottery (Med-eMonitor only) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00622102?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00622102's enrollment target sits among peer trials
101 840th of 2000 higher than 1,161 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia